Electroporation of dendritic cells with autologous total RNA from tumor material

Methods in Molecular Biology

Volumn 1139, Issue , 2014, Pages 87-95

  Milano, Francesca ^a   Krishnadath, K K ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T cells; Dendritic cells; Electroporation; RNA; Tumor

Indexed keywords

INTERLEUKIN 4; RNA; TUMOR ANTIGEN; AUTOANTIGEN; CANCER VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; AUTOLOGOUS TUMOR TOTAL RNA; B CELL LYMPHOMA; BREAST CANCER; CELL DEATH; CELL ISOLATION; COLON CANCER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ELECTROPORATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MELANOMA; MYELOMA; OVARY CANCER; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROCEDURES CONCERNING CELLS; PROSTATE CANCER; RNA ISOLATION; TUMOR BIOPSY; CELL SEPARATION; CYTOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE; METABOLISM; MONOCYTE;

ANTIGENS, NEOPLASM; AUTOANTIGENS; CANCER VACCINES; CELL SEPARATION; DENDRITIC CELLS; ELECTROPORATION; HUMANS; LYMPHOCYTES; MONOCYTES; RNA;

EID: 84909592441     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0345-0_9     Document Type: Article

References (14)

1. Erdmann M et al (2007) Effective clinical-scale production of dendritic cell vaccines by mono-cyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother 30:663-674
2. Lesterhuis WJ et al (2010) Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res 30:5091-5097
3. Morse MA, Clay TM et al (2003) HER2 dendritic cell vaccines. Clin Breast Cancer 3(Supplement 4):S164-S172
4. Pezeshki AM et al (2011) Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T cell responses. J Immunol 187:74-81
5. Ashley DM et al (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177-1182
6. Boczkowski Detal (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184: 465-472
7. Nair SK et al (1998) Induction of primary car-cinoembryonic antigen (CEA)-specific cyto-toxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 16:364-369
8. Brossart P et al (2001) The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res 61:6846-6850
9. Van Tendeloo VF et al (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98: 49-56
10. O'Neill DW et al (2004) Manipulating dendritic cell biology for the active immunother-apy of cancer. Blood 104:2235-2246
11. Porgador A et al (1996) Induction of antitu-mor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918-2926
12. Sallusto F et al (1995) Dendritic cells use mac-ropinocytosis and the mannose receptor to concentrate macromolecules in the major his-tocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389-400
13. Ponsaerts P et al (2002) Messenger RNA elec-troporation of human monocytes, followed by rapid i n vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J Immunol 169:1669-1675
14. Milano F et al (2007) An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes. J Immunol Methods 321:94-106